#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Raynaud's phenomenon Anti-myelin-associated glycoprotein associated polyneuropathy Acute myeloid leukaemia refractory Congenital leptin deficiency Metastatic gastric cancer Oropharyngeal cancer recurrent Extra-osseous Ewing's sarcoma recurrent Oesophageal atresia Malignant melanoma Leber's congenital amaurosis Acquired ATTR amyloidosis Laryngeal squamous cell carcinoma Thrombotic microangiopathy Extranodal marginal zone B-cell lymphoma (MALT type) Prader-Willi syndrome More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Basic Information Pemphigus – Trials in Disease Hereditary optic atrophy – Diagnostics Alternating hemiplegia of childhood Alveolar rhabdomyosarcoma – Basic Information Chondrosarcoma – Diagnostics Activated PI3 kinase delta syndrome – Treatment Sjogren’s syndrome – Basic Information Progressive supranuclear palsy – Basic Information Mast cell activation syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Micronised Spironolactone Propranolol Troriluzole Rgx-202 Ferric Carboxymaltose Tolebrutinib Sotatercept Dazostinag Lapatinib Nalbuphine Hydrochloride Catequentinib Dihydrochloride Vildagliptin ARGININE GLUTAMATE Bms-986442 Pitavastatin Calcium Gsk3915393 Obeticholic Acid PF-07868489 Amantadine Hemisulfate CC-97540 More therapies…

    Learn about Your Condition

    Restless legs syndrome Papulopustular rosacea EGFR gene mutation Craniocerebral injury Rectal cancer stage III Menopause Plasma cell myeloma refractory Neurogenic bladder Endometrial cancer stage III Metastases to liver Hepatic fibrosis Polymyositis Rabies Spinal muscular atrophy Hernia repair More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

B-cell small lymphocytic lymphoma

  • Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Nemtabrutinib
    • Acalabrutinib
    • Ibrutinib
    Spain

  • Study of TL-895 and Navtemadlin for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • 1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
    Hungary Poland

  • Study of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • High-grade B-cell lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    Austria France Germany Italy Spain

  • Study Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    Czechia France Hungary Poland Spain

  • Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    Investigated Drugs:
    • Zanubrutinib
    • Rituximab
    • Venetoclax
    Austria Belgium Czechia France Italy Poland +2

  • Study of Pirtobrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Pirtobrutinib
    France Italy Poland
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!